Infinity Pharma gains on promising eganelisib + nivolumab data in urothelial cancer trial
February 11 2021 - 8:02AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Infinity Pharmaceuticals (NASDAQ:INFI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Infinity Pharmaceuticals (NASDAQ:INFI)
Historical Stock Chart
From Apr 2023 to Apr 2024